ILiAD Biotechnologies, LLC
www.iliadbio.comILiAD Biotechnologies is utilizing its B-Tech vector platform to develop next generation vaccines to eradicate infectious diseases and improve lives. Its lead candidate, BPZE1, which has completed Phase 2 clinical trials, is the most advanced next generation vaccine for the prevention of whooping cough, a serious illness caused by Bordetella pertussis.
Read more
ILiAD Biotechnologies is utilizing its B-Tech vector platform to develop next generation vaccines to eradicate infectious diseases and improve lives. Its lead candidate, BPZE1, which has completed Phase 2 clinical trials, is the most advanced next generation vaccine for the prevention of whooping cough, a serious illness caused by Bordetella pertussis.
Read more
Country
State
Florida
City (Headquarters)
Weston
Industry
Employees
11-50
Founded
2012
Social
Employees statistics
View all employeesPotential Decision Makers
Executive Vice President Quality and Compliance | Data Protection Officer
Email ****** @****.comPhone (***) ****-****Executive Vice President and Chief Development Officer
Email ****** @****.comPhone (***) ****-****Vice President of Global Clinical Operations
Email ****** @****.comPhone (***) ****-****Board Member
Email ****** @****.comPhone (***) ****-****
Reach decision makers at ILiAD Biotechnologies, LLC
Free credits every month!
ILiAD Biotechnologies, LLC FAQ
Weston, United States
Biotechnology Research
